Status:
UNKNOWN
This Study Include Chronic Obstructive Pulmonary Disease(COPD) Patients . Patients Were Vitamin D Deficient Age Range 40 to 80 Years, Smokers Patients Were Advised to Take Either Placebo or Vitamin D3 . Antioxidant Enzymes Were Assessed at Baseline and at 26th Weeks.
Lead Sponsor:
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
MALE
40-80 years
Phase:
PHASE2
Brief Summary
Vitamin D3 supplementation dose not increase plasma antioxidant enzymes level in COPD patients was the null hypothesis of the research.
Detailed Description
On the first day of enrollment, the objectives, nature, purpose and potential risk of all the procedures which are intended to be used for the study will be explained in detail to each COPD patients (...
Eligibility Criteria
Inclusion
- Pulmonologist diagnosed COPD patients
- Duration of COPD: 1-10 years
- Vitamin D3 deficient : Serum 25(OH)D \<30 ng/ml
- Age: \>40years
- Sex: Male
- Socioeconomic status: Middle class
- smoker
Exclusion
- With acute exacerbation of:
- any other pulmonary diseases like - bronchial asthma respiratory tract infection bronchiectasis pneumothorax pleural effusion tuberculosis pulmonary fibrosis pneumonectomy or pulmonary lobectomy any cardiac disease, like -
- unstable angina pectoris
- congestive heart failure
- myocardial infarction
- cardiac arrhythmia
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04011930
Start Date
March 1 2019
End Date
February 28 2020
Last Update
July 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BSMMU
Dhaka, Bangladesh, 1000